For those who might believe they are being kept in the dark:
https://clinicaltrials.gov/ct2/show/NCT04181723?recrs=ad&cond=rett+syndrome&draw=2
- Forums
- ASX - By Stock
- NEU
- Ann: Update on trofinetide Phase 3 trial in Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.42%
!
$16.41

Ann: Update on trofinetide Phase 3 trial in Rett syndrome, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.41 |
Change
-0.070(0.42%) |
Mkt cap ! $2.076B |
Open | High | Low | Value | Volume |
$16.48 | $16.49 | $16.28 | $266.5K | 16.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 99 | $16.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.42 | 126 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108 | 16.430 |
1 | 99 | 16.420 |
5 | 298 | 16.410 |
4 | 256 | 16.400 |
5 | 932 | 16.390 |
Price($) | Vol. | No. |
---|---|---|
16.470 | 17 | 3 |
16.480 | 125 | 2 |
16.490 | 207 | 3 |
16.500 | 296 | 3 |
16.510 | 680 | 3 |
Last trade - 10.11am 28/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online